PMGC Holdings Inc. (ELAB)
ELAB Stock Price Chart
Explore PMGC Holdings Inc. interactive price chart. Choose custom timeframes to analyze ELAB price movements and trends.
ELAB Company Profile
Discover essential business fundamentals and corporate details for PMGC Holdings Inc. (ELAB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
21 Nov 2023
Employees
2.00
Website
https://pmgcholdings.comCEO
Graydon Bensler
Description
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California.
ELAB Financial Timeline
Browse a chronological timeline of PMGC Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 May 2026
EPS came in at -$11.21 , while revenue for the quarter reached $681.99k .
Earnings released on 26 Mar 2026
EPS came in at -$0.52 , while revenue for the quarter reached $304.14k .
Stock split effective on 10 Mar 2026
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 6 Jan 2026
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2025
EPS came in at -$19.80 , while revenue for the quarter reached $285.95k .
Stock split effective on 2 Sept 2025
Shares were split 2 : 7 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Aug 2025
EPS came in at -$6.44 .
Earnings released on 14 May 2025
EPS came in at -$40.60 .
Earnings released on 4 Apr 2025
EPS came in at -$99.99 , while revenue for the quarter reached -$1.75m .
Stock split effective on 10 Mar 2025
Shares were split 1 : 7 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 27 Nov 2024
Shares were split 1 : 200 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Nov 2024
EPS came in at -$1.37k , while revenue for the quarter reached $527.48k .
Earnings released on 14 Aug 2024
EPS came in at -$1.57k , while revenue for the quarter reached $605.53k .
Earnings released on 15 May 2024
EPS came in at -$1.57k , while revenue for the quarter reached $614.56k .
Earnings released on 29 Mar 2024
EPS came in at -$1.57k , while revenue for the quarter reached $698.59k .
Earnings released on 11 Dec 2023
EPS came in at -$0.08 , while revenue for the quarter reached $554.65k .
Earnings released on 30 Jun 2023
EPS came in at -$22.55 , while revenue for the quarter reached $316.53k .
Earnings released on 31 Mar 2023
EPS came in at -$19.04 , while revenue for the quarter reached $142.82k .
Earnings released on 31 Dec 2022
EPS came in at -$5.73 , while revenue for the quarter reached $138.90k .
Earnings released on 30 Sept 2022
EPS came in at -$4.40 , while revenue for the quarter reached $432.12k .
Earnings released on 30 Jun 2022
EPS came in at -$0.40 , while revenue for the quarter reached $170.46k .
Earnings released on 31 Mar 2022
EPS came in at -$0.91 , while revenue for the quarter reached $24.79k .
ELAB Stock Performance
Access detailed ELAB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
